These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1894865)

  • 1. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens.
    Stevenson LW; Hamilton MA; Tillisch IH; Moriguchi JD; Kobashigawa JA; Creaser JA; Drinkwater D; Laks H
    J Am Coll Cardiol; 1991 Oct; 18(4):919-25. PubMed ID: 1894865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does heart transplantation confer additional benefit over medical therapy to patients who have waited > 6 months for heart transplantation?
    Kao W; McGee D; Liao Y; Heroux AL; Mullen GM; Johnson MR; Costanzo MR
    J Am Coll Cardiol; 1994 Nov; 24(6):1547-51. PubMed ID: 7930289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation.
    Saxon LA; Wiener I; DeLurgio DB; Natterson PD; Laks H; Drinkwater DC; Stevenson WG
    Am Heart J; 1995 Sep; 130(3 Pt 1):501-6. PubMed ID: 7661067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe right ventricular dysfunction is an independent predictor of pre- and post-transplant mortality among candidates for heart transplantation.
    Ravis E; Theron A; Mancini J; Jaussaud N; Morera P; Chalvignac V; Guidon C; Grisoli D; Gariboldi V; Riberi A; Habib G; Mouly-Bandini A; Collart F
    Arch Cardiovasc Dis; 2017 Mar; 110(3):139-148. PubMed ID: 28117247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time.
    Aaronson KD; Mancini DM
    J Am Coll Cardiol; 1999 Apr; 33(5):1189-95. PubMed ID: 10193715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure.
    Frigerio M; Gronda EG; Mangiavacchi M; Andreuzzi B; Colombo T; De Vita C; Oliva F; Quaini E; Pellegrini A
    J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death and tailored medical therapy in elective candidates for heart transplantation.
    Nägele H; Rödiger W
    J Heart Lung Transplant; 1999 Sep; 18(9):869-76. PubMed ID: 10528749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit from transplantation in patients listed for heart transplantation in the United States.
    Singh TP; Milliren CE; Almond CS; Graham D
    J Am Coll Cardiol; 2014 Apr; 63(12):1169-1178. PubMed ID: 24462511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling distribution of donor hearts to maximize early candidate survival.
    Stevenson LW; Warner SL; Hamilton MA; Moriguchi JD; Chelimsky-Fallick C; Fonarow GC; Kobashigawa J; Drinkwater DC; Laks H
    Circulation; 1992 Nov; 86(5 Suppl):II224-30. PubMed ID: 1424004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected survival benefit as criterion for listing and organ allocation in heart transplantation.
    Krakauer H; Lin MJ; Bailey RC
    J Heart Lung Transplant; 2005 Jun; 24(6):680-9. PubMed ID: 15949727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.
    Sandner SE; Wieselthaler G; Zuckermann A; Taghavi S; Schmidinger H; Pacher R; Ploner M; Laufer G; Wolner E; Grimm M
    Circulation; 2001 Sep; 104(12 Suppl 1):I171-6. PubMed ID: 11568051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
    Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
    J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should stable UNOS Status 2 patients be transplanted?
    Jimenez J; Bennett Edwards L; Higgins R; Bauerlein J; Pham S; Mallon S
    J Heart Lung Transplant; 2005 Feb; 24(2):178-83. PubMed ID: 15701434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What are the criteria of priority for the patient to be accepted on the waiting list for cardiac transplantation?].
    Loisance D; Benvenuti C; Merlet P; Deleuze PH; Mazzucotelli JP; Hillion ML; Dubois-Randé JL; Castaigne A; Syrota A
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4):431-6. PubMed ID: 7646259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?
    Schmidinger H
    Am J Cardiol; 1999 Mar; 83(5B):151D-157D. PubMed ID: 10089858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of patients removed from a transplant waiting list for medical improvement: implications for organ allocation and transplantation for status 2 patients.
    Hoercher KJ; Nowicki ER; Blackstone EH; Singh G; Alster JM; Gonzalez-Stawinski GV; Starling RC; Young JB; Smedira NG
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1159-66. PubMed ID: 18455599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group.
    Deng MC; De Meester JM; Smits JM; Heinecke J; Scheld HH
    BMJ; 2000 Sep; 321(7260):540-5. PubMed ID: 10968814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it time for a cardiac allocation score? First results from the Eurotransplant pilot study on a survival benefit-based heart allocation.
    Smits JM; de Vries E; De Pauw M; Zuckermann A; Rahmel A; Meiser B; Laufer G; Reichenspurner H; Strueber M
    J Heart Lung Transplant; 2013 Sep; 32(9):873-80. PubMed ID: 23628111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Timing of Heart Transplant After HeartMate II Left Ventricular Assist Device Implantation.
    Steffen RJ; Blackstone EH; Smedira NG; Soltesz EG; Hoercher KJ; Thuita L; Starling RC; Mountis M; Moazami N
    Ann Thorac Surg; 2017 Nov; 104(5):1569-1576. PubMed ID: 28651783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. DEFIBRILAT Study Group.
    Am J Cardiol; 1991 Aug; 68(5):545-6. PubMed ID: 1872286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.